Sir Philip Campbell, Chair
Sir Philip Campbell is Editor-in-Chief of Nature and of the Nature Publishing Group. His areas of responsibility include the editorial content and management of Nature, and assuring the long-term quality of all Nature publications. He is based in London.
He has a BSc in aeronautical engineering, an MSc in astrophysics and a PhD and postdoctoral research in upper atmospheric physics. Following his research, he became the Physical Sciences Editor of Nature and then, in 1988, the founding editor of Physics World, the international magazine of the UK Institute of Physics. He returned to Nature to take on his current role in 1995.
He has worked with the UK government, the European Commission and the US National Institutes of Health on issues relating to science and its impacts in society. For ten years until 2012 he was a trustee of Cancer Research UK. He was a founding trustee of MQ before being elected Chair in 2015. He is an elected Fellow of the Royal Astronomical Society and of the Institute of Physics, has honorary degrees from several universities, and was awarded an Honorary Professorship by the Peking Union Medical College. He is a Life Member of Clare Hall, University of Cambridge. He was awarded a knighthood in the Queen’s birthday honours list of 2015 for his services to science.
Professor Christopher Fairburn
Professor Christopher Fairburn is a Wellcome Trust Principal Research Fellow and Professor of Psychiatry at the University of Oxford. He directs two research centres at Oxford, the Centre for Research on Eating Disorders and the Centre for Research on Dissemination (CREDO; credo-oxford.com). He has two main research interests: the nature and treatment of the eating disorders, and the development, evaluation and dissemination of psychological treatments. He has an international reputation in both fields. This is illustrated by the fact that he has been a recipient of both the Outstanding Researcher Award from the Academy of Eating Disorders and the Aaron Beck Prize from the Academy of Cognitive Therapy.
Professor Fairburn is a Fellow of the Academy of Medical Sciences and he has twice been a Fellow at Stanford’s Center for Advanced Study in the Behavioral Sciences. Until recently he was a Governor of the Wellcome Trust.
Dr Arash Hejazi
Dr Arash Hejazi is the Editorial Director of journals in social sciences and humanities at Wiley and Sons Inc. In his previous roles he was the Publisher of The Pharmaceutical Journal by the Royal Pharmaceutical Society and the associate publisher of Nature, where he was heavily involved in product development, product management, publishing and editorial strategic planning.
Arash Hejazi received his doctorate in medicine in 1996 from the Iran University of Medical Sciences, before launching his publishing house Caravan in 1997, the magazines Kamyaab in 2000 and Book Fiesta in 2003. In 2006 he was nominated to receive the Freedom to Publish award from the International Publishers’ Association.
He is also a novel writer, whose best known novel The Princess of the Land of Eternity was shortlisted for two major Iranian literary prizes and has sold more than 20,000 copies in Iran since its first publication in 2003. His dissertation for his MA in Publishing from Oxford Brookes University on censorship in Iran was published in the publishing journal Logos in 2011, and his memoir The Gaze of the Gazelle about growing up in Iran after the Islamic Revolution was published in 2011.
Professor Emily Holmes
Emily is the Programme Leader at the MRC Cognition and Brain Sciences Unit in Cambridge. She is also Guest Professor in Clinical Psychology at Karolinska Institutet in Sweden, Honorary Professor in Psychiatry at the University of Oxford, and a Wellcome Trust Clinical Fellow. She is a Fellow of Clare Hall, University of Cambridge, and a practicing clinical psychologist.
Within mental health science, her field is experimental psychopathology for psychological treatment innovation. Linking cognitive science with clinical psychology, psychiatry and neuroscience her team’s research focuses on trauma and mood disorders, with a particular interest in mental imagery and emotion.
She is Associate Editor of “Clinical Psychological Science”. Her research has been recognised by the British Psychological Society’s Spearman Medal (2010), Humboldt Foundation Friedrich Wilhelm Bessel Research Award (2013), and the American Psychological Association (2014).
Shaun leads Graham-Pelton Consulting in Europe, working with clients from the University, Schools, Arts and Culture and Charity sector. He has nearly two decades of fundraising, communications, and marketing experience. He was a member of the HEFCE Advisory Board for the 2014 Pearce Report into the Philanthropic Workforce for Higher Education.
Shaun also served as Director of Development and External Affairs at the University of Reading, where he led the £100M fundraising Campaign, having established fundraising from scratch at Reading in 2004. He served as Vice-Chair of the CASE Europe Board and also as a Trustee for the Phyllis Tuckwell Hospice.
Shaun spent a decade in the voluntary sector before joining Reading, working for organisations such as Plan UK, the country’s biggest child sponsorship charity at the time, and Raleigh International.
Shaun is a qualified Barrister, and is an AMP graduate from Henley Business School. He is a member of the Institute of Fundraising. He has four young children, who are a brilliant demonstration of chaos theory!
Professor Richard Morris
Richard is Professor of Neuroscience at the University of Edinburgh and an Adjunct Professor of the Norwegian Technical University in Trondheim (NTNU). He graduated in Natural Sciences at the University of Cambridge in 1969 and completed a D.Phil at the University of Sussex.
He had time out of academic life in the 1970s helping to build the Human Biology Exhibition at the Natural History Museum in London and then working for the Science and Features Department of BBC Television (on “Tomorrow’s World”). After this, he assumed a Lectureship in St Andrews before moving later to Edinburgh. During his career, he has been seconded to other activities, including the Foresight Office of the Department of Trade and Industry and, more recently, as Head of Neuroscience and Mental Health at the Wellcome Trust from 2007 to 2010. He has also been active in public awareness of science activities throughout his career, notably with the Dana Foundation. He is a member of the Council of the European Dana Alliance for the Brain.
His principal research interest is the neurobiology of learning and memory. In 1986, he made the key observation that activation of NMDA receptors in the hippocampus is critical for memory encoding. Other contributions include the development of the open-field ‘watermaze’, now used worldwide, joint development (with Julie Frey) of the ‘synaptic tagging and capture’ hypothesis and, more recently, new paradigms to study paired-associate recall in animals and gene-activation associated with the encoding and assimilation of new information into mental schemas.
He was elected to Fellowship of the Royal Society in 1997. He is also a Fellow of a number of other institutions, including the American Academy of Arts and Sciences. He has won several awards, most recently The Brain Prize (2016) for his outstanding contribution to neuroscience. Also notably the Zotterman Medal of the Swedish Physiological Society in Stockholm (1999), the Feldberg Prize (2006) and the Fondation Ipsen Neuronal Plasticity Prize (2013), and has served as President of the Federation of European Neuroscience Societies (2006-2008). He was awarded a CBE in 2007.
Edward has been with Herbert Smith Freehills, Solicitors throughout his professional career and was senior partner between 1992-2000. He is well known in the City having been involved in many high-profile cases including a number of celebrated take-over battles.
He sat on the Departmental Committee (the Cork Committee) inquiring into insolvency law between 1977-82. The report resulted in the enactment of the Insolvency Act 1986.
At the beginning of 1983, Edward was appointed as one of the first three nominated members of the Council of Lloyd’s, sitting on the Council for six years.
In 1997 Edward was asked by the Arts Council of England to conduct an independent review of the Arts Council’s relations with the Royal Opera House and in 1999 he was made a Fellow of University College London and became a visiting professor in 2000.
He has been a Governor of the South Bank Centre, on the Board of the Royal National Theatre and a Governor of The Wellcome Trust. In 2002-2003 he was one of two outsiders on the five-person National Trust Governance Working Group, which proposed radical changes to the constitution of the National Trust – now implemented.
In 2003-2004 he sat on the small advisory group assisting Sir David Clementi in his review of the regulatory framework for legal services, Sir David’s proposals subsequently being enacted in the Legal Services Act 2007. He currently acts as a non-executive director on the boards of a substantial privately owned company with significant property and commercial interests in the UK and Europe and a biotech start-up company spun out of the Wellcome Trust Sanger Institute, Cambridge.
In March 2013 he was made a Queen’s Counsel Honoris Causa.
Mike’s career in financial services began in 1963 when, at the age of 20, he joined Equity & Law as a clerk. A three-year spell at Abbey Life followed before he joined Allied Dunbar in 1971 (then known as Hambro Life), becoming Sales Director in 1976 and Group Chief Executive in 1988. In 1989 Mike was appointed to the main Board of BAT Industries who had acquired Allied Dunbar in 1985. Mike resigned from the Boards of Allied Dunbar and BAT at the end of 1990 following the announcement that he wished to start his own financial services company.
On 1 August 1991, the formation of J. Rothschild Assurance was announced and the Company was launched in January 1992 with Mike as Chief Executive. In June 1997, he was appointed to the Board of the parent company of J. Rothschild Assurance, St. James’s Place Capital as Chief Executive. In September 2004, he was appointed Chairman of St. James’s Place Capital a role which he held until the end of 2011.
In January 2012 Mike became Joint Founder and Life President of St. James’s Place as well as Principal Advisor to the St. James’s Place Academy and Chairman of the St. James’s Place Foundation.
Mike was a Trustee of the Mental Health Foundation for many years and his term as Chairman came to an end in September 2000. Between June 1993 and May 1998, Mike was a Non-Executive Director of Vendôme Luxury Group plc. In 2010, Mike became a director of MQ, when it was formally known as Insight – Research into Mental Health. His interests include tennis and racing.